Exam Master Revenue and Competitors
Estimated Revenue & Valuation
- Exam Master's estimated annual revenue is currently $5.9M per year.
- Exam Master's estimated revenue per employee is $144,000
Employee Data
- Exam Master has 41 Employees.
- Exam Master grew their employee count by 0% last year.
Exam Master's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Product Development | Reveal Email/Phone |
3 | Manager Information Services | Reveal Email/Phone |
4 | Sales Manager | Reveal Email/Phone |
5 | President and CEO | Reveal Email/Phone |
Exam Master Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.2M | 2 | -75% | N/A | N/A |
#2 | $139.5M | 620 | 7% | N/A | N/A |
#3 | $129.4M | 575 | 6% | N/A | N/A |
#4 | $6.9M | 48 | 0% | N/A | N/A |
#5 | $43M | 217 | N/A | N/A | N/A |
#6 | $7.2M | 50 | 28% | N/A | N/A |
#7 | $337.9M | 1341 | 8% | N/A | N/A |
#8 | $11.5M | 71 | 0% | N/A | N/A |
#9 | $43.8M | 221 | 6% | N/A | N/A |
#10 | $11M | 68 | 134% | N/A | N/A |
What Is Exam Master?
Exam Master® Corporation is in the business of providing exam preparation and review software to medical students (USMLE exams), residents (USMLE and Board Certification), physicians (Board Certification and SPEX) and other healthcare practioners. Our clients include medical schools, medical libraries, teaching hospitals, test-preparation consultants, and individuals all over the world. We apply the best possible combination of content and technology to the challenge of providing affordable, efficient health sciences education worldwide.
keywords:N/AN/A
Total Funding
41
Number of Employees
$5.9M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $8M | 41 | 11% | N/A |
#2 | $5.7M | 41 | 11% | N/A |
#3 | $35M | 41 | 0% | N/A |
#4 | $4.9M | 41 | 0% | N/A |
#5 | $10.8M | 41 | 3% | N/A |